Riskpilot← Back to searchSign inGet full accessDAGENS MEDISIN AS
ASActiveOrg 979914253Tullins Gate 6, 0166 OsloPublishing of journals and periodicals · NACE 5813Est. 199812 employeeswww.dagensmedisin.no
Revenue 2025
NOK 32,6M
+30% vs 2024
EBITDA margin
-5.7%
+39% vs 2024
Equity ratio
40.5%
Financial strength
Net profit 2025
NOK -1,4M
+43% vs 2024
| Revenue | NOK 32,6M | +30% |
| EBITDA | NOK -1,9M | +39% |
| Net profit | NOK -1,4M | +43% |
| Total assets | NOK 16,6M | +8% |
| Equity | NOK 6,7M | -19% |
| Employees | 12 | — |
Legal name
DAGENS MEDISIN AS
Org number
979914253
Legal form
Aksjeselskap
NACE code
5813 · Publishing of journals and periodicals
Founded
25. mars 1998
Share capital
NOK 100 000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Drive, eie/ eller delta i virksomhet innenfor publisering av medisinsk informasjon, online og på papir. Samt drive virksomhet som står naturlig i forbindelse med dette.
Address
Tullins Gate 6, 0166 Oslo
Website
www.dagensmedisin.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 30 965 | 28 401 | 27 570 | 25 020 | 32 647 |
| Staff expenses | −12 456 | −13 424 | −14 076 | −14 269 | −14 468 |
| EBITDA | 7 319 | 1 748 | −1 047 | −3 052 | −1 852 |
| Depreciation & amort. | −103 | −123 | −245 | −255 | −186 |
| EBIT | 7 216 | 1 625 | −1 293 | −3 306 | −2 039 |
| Net financials | 0 | 0 | 176 | 128 | 235 |
| Profit before tax | 7 216 | 1 705 | −1 117 | −3 179 | −1 804 |
| Tax | 1 590 | 375 | −241 | −698 | −397 |
| Net profit | 5 627 | 1 330 | −876 | −2 480 | −1 407 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 20 743 | 15 262 | 14 792 | 15 375 | 16 563 |
| Equity | 8 313 | 8 343 | 8 302 | 8 250 | 6 703 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 12 430 | 6 919 | 6 490 | 7 125 | 9 860 |
| Total debt | 12 430 | 6 919 | 6 490 | 7 125 | 9 860 |
EBITDA margin
-5.7%
This company
15.8%
Market median
-136% vs market
20212025
Equity ratio
40.5%
This company
38.2%
Market median
+6% vs market
20212025
Return on equity
-21.0%
This company
18.4%
Market median
-214% vs market
20212025
Net profit margin
-4.3%
This company
8.1%
Market median
-153% vs market
20212025
Asset turnover
1.97×
This company
1.12×
Market median
+76% vs market
20212025
Debt / equity
1.47×
This company
0.62×
Market median
-137% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TD Chief Executive Officer | Chief Executive Officer | 2021 |
FB Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bonnier News Business Ab | Company | 100% | 100% | 2024 |
Bonnier News Business Ab | Company | 100% | 100% | 2023 |
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DAGENS MEDISIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tone Danielsen | Chief Executive Officer | 0 companies |
| Fredrik Bengt Jarl Andersson | Chief Executive Officer | 0 companies |
| Lise Hjertaas | Board of Directors | 0 companies |
| Nils Arne Vilhelm Thernfrid | Board of Directors | 0 companies |
| Karmo Kaas-Lutsberg | Board of Directors | 0 companies |
| Ann Carola Henriksson | Chairman | 0 companies |